Aurora Cannabis (ACB) vs Cronos Group (CRON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Over five years, CRON leads with a -40.9% price change compared with -93.7% for ACB. Cronos Group is the larger company by market cap ($1.19 billion vs $282.4 million), about 4.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | CRON |
|---|---|---|
| Share price | $4.46 | $3.24 |
| Market cap | $282.36M | $1.19B |
| 1-day change | -2.83% | -1.37% |
| YTD return | +5.69% | — |
| 1-year return | -27.71% | — |
| 5-year return | -93.66% | -40.88% |
| P/E ratio (TTM) | — | 17.05 |
| EPS (TTM) | $-0.61 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $3.61 |
| 52-week low | $2.56 | $2.28 |
| Distance from 52-week high | -33.08% | -10.20% |
| Average volume | 1.36M | 1.14M |
| Shares outstanding | 63.31M | 368.41M |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 4.2 times larger than Aurora Cannabis by market value ($1.19B vs $282.36M).
ACB vs CRON FAQ
Which is bigger, Aurora Cannabis or Cronos Group?
Cronos Group (CRON) is larger, with a market capitalization of $1.19B compared with $282.36M for Aurora Cannabis (ACB).
Are Aurora Cannabis and Cronos Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.